Company Information

  

Address: 37 DEREH MENACHEM BEGIN ST.
15TH FLOOR 
City: TEL AVIV 
State:  
Zip Code: 6522042 
Telephone: 972 (0) 3 7326616 

Description of Business

Primary SIC Code: 2834
(As filed with the SEC)  

We are an Israeli corporation with our principal executive office located in Tel-Aviv, Israel, and were incorporated on January 22, 2012. Our legal and commercial name is Bioblast Pharma Ltd. Our principal executive offices are located at PO Box 318, Tel-Aviv, Israel 6100201, and our telephone number is: +972-3-5736632. Our wholly owned U.S. subsidiary, Bio Blast Pharma, Inc., incorporated in Delaware, has been appointed our agent in the United States and its registered address is 1811 Silverside Road, Wilmington, Delaware 19810. Our website address is https://bioblastpharma.com/. The information contained on, or that can be accessed through, our website is not part of this annual report. We have included our website address herein solely as an inactive textual reference. We are an "emerging growth company," as defined in Section 2(a) of the Securities Act of 1933, as amended, or the Securities Act, as modified by the JOBS Act.  ... More ...  

Per Share Overview

Date 12-mos Rolling EPS Dividend P/E Ratio
12/2017-1.79NAN/E
12/2016-25.25NAN/E

Key Financial Ratios and Statistics

FYE: 12/31

Profitability 2017 Leverage 2017
Net Inc/Comm Equity-0.12Total Liab/Total Assets0.13
Net Inc/Total Assets-1.64Total Liab/Inv Cap0.15
Net Inc/Inv Cap-1.88Total Liab/Comm Equity0.01
Pretax Inc/Net SalesNAInterest Coverage RatioNA
Net Inc/Net SalesNACurr Debt/EquityNA
Cash Flow/Net SalesNALTD/EquityNA
SG&A/NetSalesNATotal Debt/EquityNA
Asset Utilization   Liquidity  
Net Receivables TurnoverNAQuick Ratio7.87
Inventory TurnoverNACurrent Ratio7.87
Inventory Day SalesNANet Rec/Curr Assets0.03
Net Sales/Work CapNAInv/Curr AssetsNA
Net Sales/PP&ENA  

Income Statement (Millions)

  12/31/2017 12/31/2016 12/31/2015 12/31/2014
Total Revenues(Net Sales) NA NA NA NA
Cost of Goods Sold NA NA NA NA
Selling & Admin Exps 3.44 6.99 7.78 2.64
Operating Income -5.96 -15.87 -15.48 -7.08
Interest Exp NA NA NA NA
Pretax Income -5.92 -15.81 -15.34 -7.02
Other Income 0.04 0.06 0.14 0.06
Net Income Bef Extraordinary ... NA NA NA NA
Net Income -5.95 -16.02 -15.37 -7.02

Balance Sheet (Millions)

Assets 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Cash & Short Term Investments 3.53 6.87 7.29 10.58
Receivables - Total 0.10 0.66 1.06 0.27
Inventories - Total NA NA NA NA
Total Current Assets 3.62 10.54 20.39 32.89
Net Property, Plant & Equipment 0.00 0.07 0.09 0.06
Total Assets 3.62 10.63 20.52 32.95
Liabilities        
Accounts Payable 0.46 1.93 2.51 2.28
Debt in Current Liabilities NA NA NA NA
Total Current Liabilities 0.46 1.93 2.51 2.28
Long-Term Debt NA NA NA NA
Total Liabilities 0.46 1.93 2.58 2.28
Stockholder's Equity        
Minority Interest NA NA NA NA
Preferred Stock NA NA NA NA
Common Stock 0.05 0.05 0.04 0.04
Retained Earnings -45.75 -39.81 -23.79 -8.42
Treasury Stock NA NA NA NA
Total Stockholders' Equity 3.16 8.70 17.93 30.67
Total Liabilities and Stockholders' Equity 3.62 10.63 20.52 32.95

Cash Flow Summary (Millions)

Categories 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Net Cash Provided by Operating Activities -6.35 -15.49 -13.25 -4.41
Net Cash Provided by Investing Activities 3.01 8.98 9.95 -22.06
Net Cash Provided by Financing Activities 0.00 6.09 0.00 36.79

Annual Summary Data (Millions)

Year Sales Net Income EPS
12/20130.00-1.14--
12/20140.00-7.02--
12/20150.00-15.36--
12/20160.00-16.02-25.25
12/20170.00-5.94-1.79
Growth RatesNaN----

Stock Ownership

Type Date(Q,M) No. Owners Shares Held (000s) % Own
Institutional06/30/1841183.54




Report Date : 7/16/2018

Powered By Edgar Online © 2018EDGAR®Online, a division of Donnelley Financial Solutions. EDGAR® is a federally registered trademark of the U.S. Securities and Exchange Commission. EDGAR Online is not affiliated with or approved by the U.S. Securities and Exchange Commission.